GlobalData on MSN
HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir
Though yet to be finalised, the initial recommendation would mean the injectable PrEP would not be covered on the NHS.
Morning Overview on MSN
A one-time combination of three therapies wiped out HIV soon after infection in a lab study
HIV is famously hard to defeat because it hides. Standard treatment can drive the virus down to undetectable levels, but it ...
Emory University researchers have provided the first proof of concept in a nonhuman primate model for eliminating ...
M184V/I emerged as the dominant NRTI resistance mutation across the continents represented in the review. The clinical ...
Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help ...
HIV doesn’t discriminate, but societal barriers have left Black Americans disproportionately affected. HIV prevention options ...
The World on MSN
Fiji is in the midst of an HIV crisis
In the South Pacific archipelago of Fiji, HIV cases have spiked in the past five years. An estimated 1 in 60 adults currently lives with the virus. A drug epidemic and stigma have made the ...
The Canadian Press on MSN
Ottawa announces $5 million for HIV self-test kits, more support staffers
WINNIPEG — The federal government is dispatching 80,000 HIV self-test kits across Canada to expand access to HIV prevention.
President Dr Ronal Kumar warned the response had been “slow at best” despite Fiji recording 2,016 HIV cases in 2025.
The drugmaker’s NABJ panel brought together journalists, faith leaders, advocates and celebrities as part of a push to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results